Merchant Risk Solutions
Marketplace Monitoring
Ad Monitoring
Website Change Detection
Compliance Solutions
Payment Facilitators & ISOs
Acquiring Banks
E-commerce Marketplaces
Search Engines
Social Platforms
Find demo videos, use cases, and top resources that can help you understand how to leverage LegitScript for risk mitigation and merchant monitoring.
Addiction Treatment
Healthcare
CBD
Medium-risk merchants are on the rise across merchant portfolios. Is this due to trends in risk criteria across merchants or a change in risk rating methodology for the merchant sponsors?
Learn about recent trends in digital transactions that can lead to expensive BRAM and VIRP fines.
Blog
Webinars
Videos
Guides
Check the certification status of an addiction treatment, healthcare, or CBD website or report questionable activity.
About Us
Customers
Leadership Team
Partners
Careers
Press
By Andrea Baker
on July 22, 2024
To meet growing demands of GLP-1 medication shortages, a slew of merchants are entering the market offering alternative products such as supplements and other healthcare products, many of which pose serious health threats to consumers. Weight loss supplements are not classified as drugs and do not require FDA review or approval before going to market,…
By LegitScript Folks
on July 17, 2024
Recent LegitScript data reveals the skyrocketing promotion of both GLP-1 medications and reported ads associated with selling compounded GLP-1 medications (press release). LegitScript tackles the sale of problematic healthcare products as well as more than 60 other high-risk categories — including counterfeits, weapons, and online gambling — with a multi-pronged approach that employs big data,…
on July 16, 2024
LegitScript’s findings show both a rapid rise in demand for Healthcare Certification by businesses offering compounded GLP-1 drugs, as well as a sharp increase in problematic GLP-1 products being peddled online that are violating laws across jurisdictions worldwide and potentially endangering unsuspecting consumers.
on July 02, 2024
In a recent webinar hosted by LegitScript, Peter Szyszko, CEO of White Bullet, delved into the pressing issue of online IP infringement and how to stop it.
on April 30, 2024
Despite potentially dangerous health effects, a social media trend promoting Melanotan II continues to prevail in the market.
on April 25, 2024
LegitScript has observed a recent rise in both the popularity and regulatory scrutiny of tianeptine, an unregulated substance commonly sold in gas stations and online.
By Thea Le Fevre
on February 27, 2024
Global payment leaders use a new gun MCC to track the sale of weapons and ammo in California.
on November 14, 2023
Discover the potential impact of the FDA's proposed changes to the Dietary Supplement Health and Education Act (DSHEA) — and how it could impact your supplement business.
By Nick Steele
on August 11, 2023
LegitScript analysts uncovered the problematic product Amanita muscaria during their monitoring work. Read further to understand why it’s problematic, and how it differs from another more common psychedelic drug.
on July 28, 2023
Nootropics — when used properly — improve cognitive function. What happens when they’re misused by healthy individuals? Read further to understand what nootropic products are, and what makes them problematic. Then, download our comprehensive Nootropics FAQ.